Cash & equivalents decreased 95.7%
Cash & equivalents changed -95.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -95.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -82.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed -68.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -77.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -6932 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +57.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +109.7% from the comparable as-filed period.
Shares outstanding changed +15.7% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Stock-based compensation changed +33.7% from the comparable as-filed period.
Operating income changed +8.4% from the comparable as-filed period.
Net income changed +9.4% from the comparable as-filed period.
Working capital changed -107.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Current liabilities changed -19.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.